Artus Therapeutics
PrivateLast Round
Grant
Jul 1, 2021
Total Funding Raised
$501,189
Company Overview
Artus Therapeutics is a biotechnology company that develops small-molecule therapeutics for inflammatory and metabolic diseases by targeting gut barrier dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artus Therapeutics Comparables
Compare Artus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oncostellae | 84% | |
| Orphagen Pharmaceuticals | 80% | |
| Piton Therapeutics | 79% |
Artus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2021 | ||||
| Seed | Aug 1, 2019 |
Artus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors grew 60% MoM, reaching 1.6K.
- Jul 1, 2021
$501K grant awarded by the National Institutes of Health.
Artus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Artus Therapeutics's valuation, stock price, and market status.
Is Artus Therapeutics a public or private company?
Artus Therapeutics is a private company.
What is the current stock price of Artus Therapeutics?
Artus Therapeutics is a private company with no public stock price. Caplight tracks Artus Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Artus Therapeutics worth (valuation)?
Valuation information for Artus Therapeutics is not publicly available.
Can I buy Artus Therapeutics stock?
Artus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Artus Therapeutics's last funding round?
Artus Therapeutics's most recent funding round was Grant on July 1, 2021.
Who are the main investors in Artus Therapeutics?
Key investors in Artus Therapeutics include National Institutes of Health (NIH).
Will Artus Therapeutics IPO soon?
No public IPO plans have been announced for Artus Therapeutics.
How can I track Artus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Artus Therapeutics's secondary market activity and sign up for updates.